Top news
Lilly to offer all approved doses of Zepbound (tirzepatide) single-dose vials through LillyDirect Self Pay Pharmacy Solutions
Eli Lilly (LLY) to Offer Higher Doses of Its Weight-Loss Drug on Website
By Joel Baglole
Lilly adds highest Zepbound doses to DTC offering
By Elaine Chen
Eli Lilly to offer highest-dose Zepbound vials on LillyDirect
By Dulan Lokuwithana
All coverage
Lilly to begin direct Zepbound shipments
By Ashley Fowler
Spotlight On: Lilly's Zepbound strategy signals bigger market moves
By Jessica D'Amico
Zepbound weight loss drug becomes more affordable
By Mike Gauntner
New Tirzepatide Access and Pricing Through Self-Pay Options
By Kennedy Ferruggia
Eli Lilly announces price cut for Zepbound
By DILLON. FUHRMAN
Eli Lilly is making it cheaper and easier to buy high doses of blockbuster weight-loss drug Zepbound
By Jennifer Mattson
Lilly Launches Full Zepbound Dose Access for Obesity Through LillyDirect Self-Pay Program
By Don Tracy
Eli Lilly adds high-dose Zepbound options to lineup of cheaper vials available on self-pay website
By Zoey Becker